Share：
Share this content in WeChat
X
[Chinese][PDF]75471
• Review •
Advances of functional magnetic resonance imaging in application of tumor treatment outcome after radiotherapy or chemotherapy
CHEN Yongye  ZHANG Enlong  ZHANG Jiahui  LANG Ning  YUAN Huishu 

Cite this article as: Chen YY, Zhang EL, Zhang JH, et al. Advances of functional magnetic resonance imaging in application of tumor treatment outcome after radiotherapy or chemotherapy. Chin J Magn Reson Imaging, 2019, 10(3): 218-222. DOI:10.12015/issn.1674-8034.2019.03.012.


[Abstract] The morbidity of malignant tumor is currently ascending with years worldwide. The accurate tumor treatment outcome after radiotherapy or chemotherapy is significantly correlating to the treatment planning. Functional magnetic resonance imaging can provide functional and metabolic information of the tumor tissue without invasion, possessing superior application value in tumor treatment outcome. Nevertheless, different sequences have different advantages and deficiencies respectively. This review is aimed to introduce the advances of multiple sequences in application of tumor treatment outcome so as to better applying it into clinic.
[Keywords] magnetic resonance imaging；radiotherapy；chemotherapy, adjuvant

CHEN Yongye Department of Radiology, Peking University Third Hospital, Beijing 100191, China

ZHANG Enlong Departmrnt of Radiology, Peking University International Hospital, Beijing 102206, China

ZHANG Jiahui Department of Radiology, Peking University Third Hospital, Beijing 100191, China

LANG Ning* Department of Radiology, Peking University Third Hospital, Beijing 100191, China

YUAN Huishu Department of Radiology, Peking University Third Hospital, Beijing 100191, China

*Correspondence to: Lang N, E-mail: 13501241339@126.com

Conflicts of interest   None.

ACKNOWLEDGMENTS  This work is part of National Natural Science Foundation in China No. 81701648, 81471634
Received  2018-12-10
Accepted  2019-01-20
DOI: 10.12015/issn.1674-8034.2019.03.012
Cite this article as: Chen YY, Zhang EL, Zhang JH, et al. Advances of functional magnetic resonance imaging in application of tumor treatment outcome after radiotherapy or chemotherapy. Chin J Magn Reson Imaging, 2019, 10(3): 218-222. DOI:10.12015/issn.1674-8034.2019.03.012.

[1]
Santa-Maria CA, Camp M, Cimino-Mathews A, et al. Neoadjuvant therapy for early-stage breast cancer: current practice, controversies, and future directions. Oncology (Williston Park), 2015, 29(11): 828-838.
[2]
Iima M, Le Bihan D. Clinical intravoxel incoherent motion and diffusion MR imaging: past, present, and future. Radiology, 2016, 278(1): 13-32.
[3]
Le Bihan D. Apparent diffusion coefficient and beyond: what diffusion MR imaging can tell us about tissue structure. Radiology, 2013, 268(2): 318-322.
[4]
Afaq A, Andreou A, Koh DM. Diffusion-weighted magnetic resonance imaging for tumour response assessment: why, when and how? Cancer Imaging, 2010,10 (1A): S179-S188.
[5]
Wang L, Han C, Zhu S, et al. Investigation of using diffusion-weighted magnetic resonance imaging to evaluate the therapeutic effect of esophageal carcinoma treatment. Oncol Res Treat, 2014, 37(3): 112-116.
[6]
McLaughlin RL, Newitt DC, Wilmes LJ, et al. High resolution in vivo characterization of apparent diffusion coefficient at the tumor-stromal boundary of breast carcinomas: a pilot study to assess treatment response using proximity-dependent diffusion-weighted imaging. J Magn Reson Imaging, 2014, 39(5): 1308-1313.
[7]
Xu HD, Zhang YQ, Shen WY, et al. Diffusion-weighted imaging in evaluating the efficacy of concurrent chemoradiotherapy in the treatment of non-small cell lung cancer. Tumori, 2018, 104(3): 188-195.
[8]
Lambregts DM, Rao SX, Sassen S, et al. MRI and diffusion-weighted MRI volumetry for identification of complete tumor responders after preoperative chemoradiotherapy in patients with rectal cancer: a Bi-institutional validation study. Ann Surg, 2015, 262(6): 1034-1039.
[9]
Schelhorn J, Best J, Reinboldt MP, et al. Does diffusion-weighted imaging improve therapy response evaluation in patients with hepatocellular carcinoma after radioembolization? Comparison of MRI using Gd-EOB-DTPA with and without DWI. J Magn Reson Imaging, 2015, 42(3): 818-827.
[10]
Iima M, Le Bihan D. Clinical Intravoxel Incoherent Motion and Diffusion MR Imaging: Past, Present, and Future. Radiology, 2016, 278(1): 13-32.
[11]
Zhu L, Zhu L, Shi H, et al. Evaluating early response of cervical cancer under concurrent chemo-radiotherapy by intravoxel incoherent motion MR imaging. BMC Cancer, 2016, 16(1): 79.
[12]
Gaeta M, Benedetto C, Minutoli F, et al. Use of diffusion-weighted, intravoxel incoherent motion, and dynamic contrast-enhanced MR imaging in the assessment of response to radiotherapy of lytic bone metastases from breast cancer. Acad Radiol, 2014, 21(10): 1286-1293.
[13]
Lerner A, Mogensen MA, Kim PE, et al. Clinical applications of diffusion tensor imaging. World Neurosurg, 2014, 82(1-2): 96-109.
[14]
Castellano A, Donativi M, Ruda R, et al. Evaluation of low-grade glioma structural changes after chemotherapy using DTI-based histogram analysis and functional diffusion maps. Eur Radiol, 2016, 26(5): 1263-1273.
[15]
Furman-Haran E, Nissan N, Ricart-Selma V, et al. Quantitative evaluation of breast cancer response to neoadjuvant chemotherapy by diffusion tensor imaging: initial results. J Magn Reson Imaging, 2018, 47(4): 1080-1090.
[16]
Liu C, Bammer R, Acar B, et al. Characterizing non-Gaussian diffusion by using generalized diffusion tensors. Magn Reson Med, 2004, 51(5): 924-937.
[17]
Wedeen VJ, Wang RP, Schmahmann JD, et al. Diffusion spectrum magnetic resonance imaging (DSI) tractography of crossing fibers. Neuroimage, 2008, 41(4): 1267-1277.
[18]
Jensen JH, Helpern JA, Ramani A, et al. Diffusional kurtosis imaging: the quantification of non-gaussian water diffusion by means of magnetic resonance imaging. Magn Reson Med, 2005, 53(6): 1432-1440.
[19]
Chen Y, Ren W, Zheng D, et al. Diffusion kurtosis imaging predicts neoadjuvant chemotherapy responses within 4 days in advanced nasopharyngeal carcinoma patients. J Magn Reson Imaging, 2015, 42(5): 1354-1361.
[20]
Jensen JH, Helpern JA, Ramani A, et al. Diffusional kurtosis imaging: the quantification of non-gaussian water diffusion by means of magnetic resonance imaging. Magn Reson Med, 2005, 53(6): 1432-1440.
[21]
Currie S, Hadjivassiliou M, Craven IJ, et al. Magnetic resonance spectroscopy of the brain. Postgrad Med J, 2013, 89(1048): 94-106.
[22]
Lotumolo A, Caivano R, Rabasco P, et al. Comparison between magnetic resonance spectroscopy and diffusion weighted imaging in the evaluation of gliomas response after treatment. Eur J Radiol, 2015, 84(12): 2597-2604.
[23]
Cecil KM. Proton magnetic resonance spectroscopy: technique for the neuroradiologist. Neuroimaging Clin N Am, 2013, 23(3): 381-392.
[24]
Huang Z, Yuh KA, Lo SS, et al. Validation of optimal DCE-MRI perfusion threshold to classify at-risk tumor imaging voxels in heterogeneous cervical cancer for outcome prediction. Magn Reson Imaging, 2014, 32(10): 1198-1205.
[25]
Li X, Arlinghaus LR, Ayers GD, et al. DCE-MRI analysis methods for predicting the response of breast cancer to neoadjuvant chemotherapy: pilot study findings. Magn Reson Med, 2014, 71(4): 1592-1602.
[26]
Chakiba C, Cornelis F, Descat E, et al. Dynamic contrast enhanced MRI- derived parameters are potential biomarkers of therapeutic response in bladder carcinoma. Eur J Radiol, 2015, 84(6): 1023-1028.
[27]
Dutoit JC, Claus E, Offner F, et al. Combined evaluation of conventional MRI, dynamic contrast-enhanced MRI and diffusion weighted imaging for response evaluation of patients with multiple myeloma. Eur J Radiol, 2016, 85(2): 373-382.

PREV Progress in the application of magnetic resonance multi-sequence diagnosis to evaluate acute myocardial infarction
NEXT Present research situation of the MRI manifastations of spinal infection and its imitations
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn